SL-V10

N/A

Report date: 2026/04/22 20:01:10

Base Information

Drug NameSL-V10
Drug Alias NameBD-03SL-V10
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsBK Polyomavirus InfectionsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSl Vaxigen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSl VaxigenSL BIGEN Co Ltd
Active IndicationsN/A
Inactive IndicationsBK Polyomavirus InfectionsCytomegalovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A